Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of biomedical fibrin glue serving as medicament for treating lacrimal duct obstruction diseases

A technology of biological protein glue and lacrimal duct obstruction, which can be applied in the direction of sensory diseases, drug combination, pharmaceutical formula, etc., can solve the problems of package damage, glue discarding, etc., and achieve the effect of preventing adhesion and promoting wound healing

Inactive Publication Date: 2012-08-15
高传友
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0069] 5. If the nozzle or needle is blocked during use, it needs to be replaced
[0076] 3. It must be used up within 4 hours after preparation
[0077] 4. The leftover glue should be discarded
[0078] 5. The product is for one-time use and has been sterilized. If the package is damaged, it is forbidden

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of biomedical fibrin glue serving as medicament for treating lacrimal duct obstruction diseases
  • Application of biomedical fibrin glue serving as medicament for treating lacrimal duct obstruction diseases
  • Application of biomedical fibrin glue serving as medicament for treating lacrimal duct obstruction diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0092] refer to figure 2 For the treatment of lacrimal duct obstruction, a sterile disposable double-chamber liquid pusher 3 is used, and a sterile disposable needleless needle 4 is used for the needle.

[0093] refer to Figure 1 to Figure 4 , the method and operation steps for the treatment of lacrimal duct obstruction are as follows (the bioprotein glue and related equipment adopted are listed below):

[0094] 1. Use the lacrimal duct dilator to expand the lacrimal puncta;

[0095] 2. Use the laser generated by the model HGL-MYK8M KTP laser therapy instrument (manufactured by Wuhan Huagong Laser Medical Equipment Co., Ltd.) to open up the lacrimal duct adhesions;

[0096] 3. Insert the pointless needle (such as a pointless needle of 0.5 mm) of the double-chamber liquid pusher (such as a 0.5 mm pointless needle) into the puncta of the punctum by preparing the main body glue solution in one cavity and preparing the catalyst solution in another cavity, and push the liquid t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention provides application of biomedical fibrin glue serving as a medicament for treating lacrimal duct obstruction diseases, and relates to a biochemical fibrin glue medicament applied to treatment of lacrimal duct obstruction diseases. The application of the biomedical fibrin glue serving as the medicament for treating lacrimal duct obstruction diseases is characterized in that: the biochemical fibrin glue has excellent effect in treating lacrimal duct obstruction diseases, and is used in treatment of the lacrimal duct obstruction diseases. The cure rate of patients who are not injected with biochemical fibrin glue is 30 percent, while the cure rate of patients who are injected with biochemical fibrin glue is between 70 and 75 percent, so that the biochemical fibrin glue has remarkable curative effect.

Description

technical field [0001] The invention relates to the technical field of ophthalmic lacrimal duct in clinical medicine, in particular to a bioprotein glue drug used for treating eye lacrimal duct obstruction diseases. Background technique [0002] The treatment of lacrimal duct obstruction has multiple methods such as simple lacrimal duct laser, high-frequency electric therapy, and lacrimal duct tube (putting lacrimal duct stick) treatment, but the cure rate is relatively low (for example, the cure rate of simple lacrimal duct laser is about 30%), and it is easy to form scars and membranous tissue adhesions to varying degrees. [0003] Chinese Patent Application No. 200410017526.7 discloses a treatment method of lacrimal duct stick, and its cure rate also needs to be improved, and its treatment method needs to take out the lacrimal duct holder after a period of time. [0004] The medical biological protein glue (or fibrin sealant or fibrin gel) produced by a limited company h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/36A61P27/02
Inventor 高传友
Owner 高传友
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com